Skip to main content
. 2019 Jan 25;39(1):BSR20181804. doi: 10.1042/BSR20181804

Figure 1.

Figure 1

FBXL19-AS1 is up-regulated in lung cancer tissues and cell lines and relates to poor prognosis of patients

(A) RT-qPCR results showed that expression of FBXL19-AS1 was higher in tumor tissues than in adjacent non-tumor tissues. (B) RT-qPCR results showed that expression of FBXL19-AS1 was higher in lung cancer cell lines (A549, H1299, H1975, H125, and SPC-A-1) than in normal human lung cells (MRC-5). (C) Relative FBXL19-AS1 expression levels in different clinical stages (I-II and III-IV). (D) Kaplan–Meier curve and the log-rank test showed that the expression of FBXL19-AS1 was associated with overall survival in patients with lung cancer. Error bars represent the mean ± SD of at least three independent experiments. **P<0.01 versus control group.